Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Goodbody Health Ltd GDBYF

Goodbody Health Ltd is a wellness company operating in both COVID testing in the United Kingdom and as a vertically integrated cannabinoid CBD company that operates in the United Kingdom and the European Union. It has interests in COVID testing clinics, CBD extraction, wholesale bulk isolate, and distillate sales, retail CBD and white label sales, cannabinoid laboratory testing, and medicinal cannabis research programs.


GREY:GDBYF - Post by User

Post by Uknowiton Nov 19, 2019 11:35am
79 Views
Post# 30369629

Stil burn rate

Stil burn rate

I have spoken with Jason on this subject and their burn rate is roughly $180 k per month. The next financials will show that to be the case. Significant $ have been spent on work being done on the Nexus and Origin facilities but that is pretty much done now. They still have $10-11 mil in the bank and will be adding close to $7 mil to that this month from sales to Bioscience and Sequoya.


They are not dead, not broke or even close to either. The rest of this month and December will prove that out. They have used their money wisely and will never have to do a raise again. Revenue just starting now and should be close to $30 mil from December through February. That's their next financial quarter. 


Additonally, they will be quick to show revenue from November. Once they do they can announce more isolate deals (remember from the last NR "new and existing customers". My understanding is that neutraceutical deals are also in the works.  

<< Previous
Bullboard Posts
Next >>